NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 13 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,027 | +60.2% | 44,000 | 0.0% | 0.00% | – |
| Q2 2023 | $24,992 | -9.1% | 44,000 | 0.0% | 0.00% | – |
| Q1 2023 | $27,500 | -20.3% | 44,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $34,518 | +23.3% | 44,000 | +12.8% | 0.00% | – |
| Q3 2022 | $28,000 | +12.0% | 39,000 | 0.0% | 0.00% | – |
| Q2 2022 | $25,000 | -7.4% | 39,000 | 0.0% | 0.00% | – |
| Q1 2022 | $27,000 | 0.0% | 39,000 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | -46.0% | 39,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $50,000 | -12.3% | 39,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $57,000 | -1.7% | 39,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $58,000 | -23.7% | 39,000 | -22.0% | 0.00% | 0.0% |
| Q4 2020 | $76,000 | +94.9% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $39,000 | +129.4% | 50,000 | 0.0% | 0.00% | – |
| Q2 2020 | $17,000 | +112.5% | 50,000 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | -27.3% | 50,000 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | -8.3% | 50,000 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moloney Securities Asset Management, LLC | 352,660 | $320,815 | 0.06% |
| Opus Capital Group, LLC | 60,150 | $55 | 0.01% |
| AlphaMark Advisors, LLC | 14,007 | $13 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $9 | 0.00% |
| LEE DANNER & BASS INC | 20,000 | $18 | 0.00% |
| Williams Jones Wealth Management, LLC. | 44,000 | $40,027 | 0.00% |
| MAI Capital Management | 20,000 | $18,194 | 0.00% |
| Bartlett & Co. LLC | 4,292 | $4 | 0.00% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% |